The "ZERMAVA" trademark, serial number 86019100 , was filed on 24th of July 2013 with a mark drawing code of 4000 and its transaction date is 86019100. Since 28th of March 2014, the document can be found in the L30 law office in the publication and issue section. The employee responsible is MCBRIDE, THEODORE M and the date it was published for opposition on 12/17/2013. The status of this trademark was checked last on 03/28/2014.

The corresponded responsible for this trademark is BRUCE W. LONGBOTTOM, located at ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN 46285-0001.

The state or country where the trademark was organized is IN by Eli Lilly And Company. The legal entity type behing it is a Corporation, located at Lilly Corporate Center, Indianapolis, IN zip 46285.Other trademarks by this applicant: ZIPSTA, RECUVYRA, AMYVID.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	8 - Abandoned
Status Date	03/28/2014
Primary Code	005
Goods codes
GS0051	Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases

PROSECUTION HISTORY
Date	Description	Type	Code
12/17/2013	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	E	NPUB - NOTICE OF PUBLICATION
03/28/2014	ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	O - Outgoing Correspondence	MAB5 - ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
03/28/2014	ABANDONMENT - AFTER PUBLICATION	O - Outgoing Correspondence	ABN5 - ABANDONMENT - AFTER PUBLICATION
03/27/2014	TEAS EXPRESS ABANDONMENT RECEIVED	I - Incoming Correspondence	EXAR - TEAS EXPRESS ABANDONMENT RECEIVED
01/14/2014	EXTENSION OF TIME TO OPPOSE RECEIVED	T - TTAB Proceeding	ETOF - EXTENSION OF TIME TO OPPOSE RECEIVED
12/17/2013	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
11/27/2013	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	E	NONP
11/08/2013	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2013	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
07/30/2013	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
07/27/2013	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.